الرئيسية › داء كرون › نيويورك › New York City
التجارب السريرية لـ داء كرون في New York City، NY
35 دراسات لـ داء كرون تبحث عن مشاركين في مواقع داخل وحول New York City (ضمن نطاق 30 ميلًا تقريبًا). افتح الدراسة لمعرفة من يمكنه المشاركة وكيفية التواصل مع فريق الدراسة.
النص الرسمي للدراسة (بالإنجليزية)
تبحث عن مشاركين لدراسة؟ أبرزها في أعلى الصفحة — $99 لمدة 30 يومًا →
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
جارٍ التسجيلالمرحلة 2
- New York Gastroenterology Associates - Upper East Side /ID# 281767, New York
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
جارٍ التسجيلالمرحلة 1
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
جارٍ التسجيلالمرحلة 3
- New York Gastroenterology Associates ( Site 0253), New York
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
جارٍ التسجيلالمرحلة 3
- NYU Langone Health - Inflammatory Bowel Disease Center (IBD) ( Site 5078), New York
- Weill Cornell Medical College, New-York Presbyterian Hospital ( Site 5079), New York
- New York Gastroenterology Associates ( Site 5013), New York
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
جارٍ التسجيلالمرحلة 4
- New York Gastroenterology Associates, New York
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
جارٍ التسجيلالمرحلة 2
- Northwell Health-Lenox Hill Hospital /ID# 265527, New York
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
جارٍ التسجيلالمرحلة 3
- Weill Cornell Medical College - Judith Jaffe Multiple Sclerosis Center, New York
- Icahn School of Medicine at Mount Sinai, New York
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
جارٍ التسجيلالمرحلة 2
- Icahn School of Medicine at Mount Sinai (ISMMS) - The Mount Sinai Hospital (MSH), New York
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
جارٍ التسجيلالمرحلة 3
- New York Gastroenterology Associates, New York
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
جارٍ التسجيلالمرحلة 2/3
- Inflammatory Bowel Disease Center at NYU Langone, New York
- Weill Cornell Medical College, New York
- Lenox Hill Hospital, New York
- و 1 أخرى
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
جارٍ التسجيلالمرحلة 3
- New York Gastroenterology Associates, New York
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
جارٍ التسجيلالمرحلة 3
- Manhattan Clinical Research, LLC-Site Number: 8400069, New York
- NYU Langone Health-Site Number: 8400091, New York
- Columbia University Medical Center-Site Number: 8400138, New York
- و 2 أخرى
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
جارٍ التسجيلالمرحلة 3
- NYU Langone Health-Site Number: 8400091, New York
- Weill Cornell Medicine - NewYork-Presbyterian Hospital-Site Number: 8400040, New York
- New York Gastroenterology Associates-Site Number: 8400009, New York
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
جارٍ التسجيلالمرحلة 3
- Icahn School of Medicine at Mount Sinai /ID# 254880, New York
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
جارٍ التسجيلالمرحلة 3
- Icahn School of Medicine at Mount Sinai, New York
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
جارٍ التسجيلالمرحلة 4
- NYU Langone Health, New York
Standardized Microbiota Transplant Therapy in Crohn's Disease
جارٍ التسجيلالمرحلة 2
- NYU Langone Health, New York
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
جارٍ التسجيلالمرحلة 3
- New York Gastroenterology Associates, New York
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
جارٍ التسجيلالمرحلة 3
- Weill Cornell Medical College (WCMC) - Judith Jaffe Multiple Sclerosis Center (JJMSC), New York
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Medical Center/New York Presbyterian, New York
Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease
جارٍ التسجيلالمرحلة 3
- Weill Cornell Medicine, New York
Behavioral Therapy for Crohn's Disease
جارٍ التسجيل
- Icahn School of Medicine at Mount Sinai, New York
- New York Gastroenterology Associates, New York
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
جارٍ التسجيل
- NYU Langone Health, New York
- Cornell University, New York
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
جارٍ التسجيلدراسة رصدية
- New York University, New York
Low Dose IL-2 for the Treatment of Crohn's Disease
جارٍ التسجيلالمرحلة 1/2
- Mount Sinai, New York
Autologous Stem Cell Transplant for Crohn's Disease
جارٍ التسجيلالمرحلة 2
- Icahn School of Medicine at Mount Sinai, New York
Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
جارٍ التسجيلالمرحلة 3
- Icahn School of Medicine at Mount Sinai /ID# 262216, New York
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
جارٍ التسجيلالمرحلة 3
- New York Presbyterian Hospital, New York
Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease
جارٍ التسجيلالمرحلة 2
- Icahn School of Medicine at Mount Sinai, New York
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
جارٍ التسجيلالمرحلة 3
- Columbia University Medical Center, New York-Presbyterian Hospital, New York
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
جارٍ التسجيلالمرحلة 4
- Columbia University Medical Center, New York
Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis
جارٍ التسجيل
- Weill Cornell Medical College, New York
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
جارٍ التسجيلالمرحلة 2
- Mirador Therapeutics Selected Site, New York
Pregnant Women With and Without Crohns Disease to Explore the Role of Plastics and Toxins in Intestinal Inflammation
جارٍ التسجيلدراسة رصديةمرحباً بالمتطوعين الأصحاء
- Icahn School of Medicine at Mount Sinai, New York
Treatment of Moderate to Severe Refractory Crohn's Disease
جارٍ التسجيلالمرحلة 1/2
- Mount Sinai Health Systems, New York
Helmsley 3.0: Abbreviated MRE
جارٍ التسجيلدراسة رصدية
- NYU Langone, New York
تجارب داء كرون في مدن أخرى
- Boston, MA19 دراسات
- Miami, FL19 دراسات
- Cleveland, OH19 دراسات
- St. Louis, MO19 دراسات
- Tyler, TX17 دراسات
- Orlando, FL17 دراسات
- Houston, TX17 دراسات
- Atlanta, GA17 دراسات
- San Antonio, TX15 دراسات
- Los Angeles, CA15 دراسات
- San Diego, CA15 دراسات
- Colorado Springs, CO13 دراسات
دراسات أخرى في New York City
- سرطان الثدي136 دراسات
- سرطان الرئة غير صغير الخلايا121 دراسات
- السرطان (جميع الأنواع)109 دراسات
- سرطان البروستاتا103 دراسات
- السرطان النقيلي93 دراسات
- سرطان القولون والمستقيم78 دراسات
- سرطان المبيض69 دراسات
- سرطان الرئة60 دراسات
- الورم النقوي المتعدد60 دراسات
- سرطان البنكرياس60 دراسات
- سرطان بطانة الرحم52 دراسات
- ابيضاض الدم النقوي الحاد51 دراسات
من ClinicalTrials.gov، البيانات مستخرجة في 06/10/2026. كل دراسة تحدد معايير أهليتها الخاصة؛ فريق الدراسة هو من يحدد من يمكنه المشاركة.